Molecular diagnostic testing for infectious diseases using TMA technology

Expert Review of Molecular Diagnostics

Volumn 1, Issue 4, 2001, Pages 445-455

  Hill, Craig S ^a  

^a Gen Probe Incorporated   (United States)

Author keywords

Amplification; Blood bank testing; Chlamydia trachomatis; Diagnostic testing; HCV; HIV; Mediated amplification; Molecular nucleic acid probes; Myobacterium tuberculosis; Neisseria gonorrhoeae; Nucleic acid; Transcription

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; CHLAMYDIA TRACHOMATIS; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MEDICAL TECHNOLOGY; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PERFORMANCE; SAFETY; TRANSCRIPTION MEDIATED AMPLIFICATION;

EID: 0035557630     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.1.4.445     Document Type: Article

References (47)

1. Nucleic acid probe specific for members of the genus Legionella
2. Chemiluminescent DNA probes: A comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays
3. Detection of acridimium esters by chemiluminescence
4. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium ester-labeled DNA probes
5. Detection and identification of Mycobacterium directly from BACTEC bottles by using a DNA-rRNA probe
6. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii and Mycobacterium gordonae directly from BACTEC TB broth cultures
7. Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory
8. Detection of Chlamydia trachomatis endocervical infection in asymptomatic and symptomatic women: Comparison of Gen-Probe PACE 2 DNA probe test and tissue culture
9. Comparative evaluation of detection assays for Chlamydia trachomatis
10. Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories
11. DNA probe assays for the detection of sexually transmitted diseases
12. Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens
13. Comparison of the Gen-Probe Group A Streptococcus Direct Test with culture and a rapid streptococcal antigen detection assay for diagnosis of streptococcal pharyngitis
14. Molecular detection and identification of microorganisms
15. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity
16. Reproducibility problems with the abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae
17. Reproducibility problems with the amplicor PCR Chlamydia trachomatis test
18. Evaluation of amplicor Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR
19. Simultaneous detection of multiple nucleic acid targets in a homogeneous format
20. Current laboratory methods for the diagnosis of tuberculosis
21. Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe amplified mycobacterium tuberculosis direct test
22. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA
23. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis. Results of a multicenter prospective trial
24. Clinical evaluation of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid detection for Mycobacterium tuberculosis in select nonrespiratory specimens
25. Comparison of enhanced mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens
26. Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates
27. Comparative Evaluation of initial and new versions of the Gen-Probe amplified mycobacterium tuberculosis direct test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens
28. Comprehensive evaluation of performance, laboratory application and clinical usefulness of two direct amplification technologies for the detection of Mycobacterium tuberculosis complex
29. Evaluation of three nucleic acid amplification methods for direct detection of Mycobacterium tuberculosis complex in respiratory specimens
30. Enhanced mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in positive ESP II broth cultures of nonrespiratory specimens
31. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
32. Chlamydial infections
33. Molecular techniques for the laboratory identification of Chlamydia trachomatis
34. Comparative evaluation of detection assays for Chlamydia trachomatis
35. Limited value of two widely used enzyme immunoassays for detection of Chlamydia trachomatis in women
36. Cost-effectiveness of combined treatment for endocervical gonorrhea considering co-infection with Chlamydia trachomatis
37. Nucleic acid amplification technologies to diagnose Chlamydia trachomatis genital infection: A promise still unfulfilled
38. Comparison of three nucleic acid amplification tests and N. gonorrhoeae culture for the detection of C. Trachomatis and N. gonorrhoeae using a rotating standard
39. The effect of urine testing in evaluations of the sensitivity of Gen-Probe APTIMA Combo 2 Assay on cervical swabs for Chlamydia trachomatis. The infected patient standard reduces sensitivity of single site evaluation
40. Multicenter clinical trial performance of the new Gen-Probe APTIMA Combo 2 assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae in female and male urine specimens
41. Comparison of the Gen-Probe APTIMA Combo 2 Assay with chlamydial culture and the PCR and LCR diagnostic tests
42. APTIMA Combo 2 analytical performance with C. trachomatis and N. gonorrhoeae
43. Lack of female urinary inhibitors to Chlamydia trachomatis nucleic acid amplification in the Gen-Probe APTIMA Combo 2 assay
44. Transcription-mediated amplification assays for blood-screening. HIV-1/HCV assay, HIV-1/HCV/HBV triplex, HIV-1/HCV/HBV discriminatory assays
45. Detection of HIV-1 and HCV amplification products
46. Nucleic acid amplification technology of the United States and Canadian Blood Supply
47. Automating nucleic acid amplification tests